AI assistant
KALA BIO, Inc. — Director's Dealing 2017
Jul 19, 2017
35091_dirs_2017-07-19_ea2bc1f2-252d-4f7b-8897-0bb7be8ba29b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Kala Pharmaceuticals, Inc. (KALA)
CIK: 0001479419
Period of Report: 2017-07-19
Reporting Person: Reumuth Mary (Chief Financial Officer, 10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.30 | 2024-10-02 | Common Stock (11520) | Direct | |
| Stock Option (right to buy) | $2.30 | 2024-10-02 | Common Stock (11520) | Direct | |
| Stock Option (right to buy) | $2.30 | 2024-12-04 | Common Stock (15360) | Direct | |
| Stock Option (right to buy) | $5.21 | 2025-10-02 | Common Stock (5077) | Direct | |
| Stock Option (right to buy) | $3.34 | 2026-06-17 | Common Stock (92096) | Direct |
Footnotes
F1: This option was granted on October 2, 2014 and vests over four years, with 25% of the shares underlying the option vested on February 3, 2015, and an additional 2.0833% of the shares underlying the option vesting at the end of each successive one-month period thereafter.
F2: This option was granted on October 2, 2014 and vests over four years, with to 25% of the shares underlying the option vested on August 18, 2015, and an additional 2.0833% of the shares underlying the option vesting at the end of each successive one-month period thereafter.
F3: This option was granted on December 4, 2014 and vests over four years, with 25% of the shares underlying the option vested on December 4, 2015 and an additional 2.0833% of the shares underlying the option vesting at the end of each successive one-month period thereafter.
F4: This option was granted on October 2, 2015 and vests over four years, with 25% of the shares underlying the option vested on October 2, 2016, and an additional 2.0833% of the shares underlying the option vesting at the end of each successive one-month period thereafter.
F5: This option was granted on June 17, 2016 and vests over four years, with 25% of the shares underlying the option vested on June 17, 2017, and an additional 2.0833% of the shares underlying the option vesting at the end of each successive one-month period thereafter.